Assessment of liver fibrosis by acoustic radiation force impulse elastography in rheumatic disease patients on long-term methotrexate treatment

Background: Methotrexate treatment has been associated with liver fibrosis in patients with rheumatic disease. Liver biopsy has been the gold standard for staging liver fibrosis. Acoustic Radiation Force Impulse (ARFI) imaging is a new accurate, non-invasive method for staging liver fibrosis. Till d...

Full description

Saved in:
Bibliographic Details
Main Authors: Arindam Nandy Roy, Gayatri Senapathy, Vijay Kumar Bongu, Yarram Ashok Kumar, Syeda Sana Fatima, Regina Lata Thadigiri
Format: Article
Language:English
Published: SAGE Publishing 2020-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=2;spage=111;epage=115;aulast=Roy
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841561356627607552
author Arindam Nandy Roy
Gayatri Senapathy
Vijay Kumar Bongu
Yarram Ashok Kumar
Syeda Sana Fatima
Regina Lata Thadigiri
author_facet Arindam Nandy Roy
Gayatri Senapathy
Vijay Kumar Bongu
Yarram Ashok Kumar
Syeda Sana Fatima
Regina Lata Thadigiri
author_sort Arindam Nandy Roy
collection DOAJ
description Background: Methotrexate treatment has been associated with liver fibrosis in patients with rheumatic disease. Liver biopsy has been the gold standard for staging liver fibrosis. Acoustic Radiation Force Impulse (ARFI) imaging is a new accurate, non-invasive method for staging liver fibrosis. Till date, no study has been conducted to evaluate the diagnostic value of ARFI in patients with rheumatic disease undergoing methotrexate treatment. Study Objective: To assess the degree of liver fibrosis with non-invasive ARFI and to compare the findings with the biochemical parameters in rheumatic disease patients taking methotrexate for long duration. Study Method: We reviewed the medical records of rheumatoid arthritis patients who were administered methotrexate for more than 2 years. A total of 151 patients with rheumatic disease, aged ≥ 18 years were enrolled into the study. In addition, 24 healthy subjects (controls) were recruited to compare the ARFI values with that of patients with rheumatic disease. On the day of the ARFI examination, a series of biochemical parameters were also assessed in the patient group. Pre-defined cut-off ARFI values were used to assess the stage of liver disease. Results: The mean ARFI value in the patient group was 1.14. The mean ARFI values of different rheumatic disease patients were 1.13 (0.0), 1.26 (0.19), 1.16 (0.15), 0.945 (0.21) for Rhupus, rheumatoid arthritis, psoriatic arthritis and Sjogren's syndrome, respectively. Biochemical abnormalities (ALT/AST) were seen in 33 (21.85%) patients. Three patients had ARFI abnormalities (1: cirrhosis and 2: early stage fibrosis). There was no correlation between the ARFI values / biochemical parameters and the cumulative dose of methotrexate. However, the ARFI values correlated with the aspartate aminotransferase (AST), alanine aminotransferase (ALT) and AST to platelet ratio index. Liver fibrosis is rare in rheumatoid arthritis patients treated with a high cumulative dose of methotrexate, and is not accurately detected in patients with liver enzyme abnormalities. Conclusion: Considering the risk and benefit ratio of liver biopsy, ARFI may be a useful non- invasive diagnostic tool for the monitoring hepatic toxicity in patients with rheumatic disease undergoing methotrexate treatment.
format Article
id doaj-art-b79c8afb2b8a417fb658b0dce55d7aa3
institution Kabale University
issn 0973-3698
0973-3701
language English
publishDate 2020-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Rheumatology
spelling doaj-art-b79c8afb2b8a417fb658b0dce55d7aa32025-01-03T01:45:44ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012020-01-0115211111510.4103/injr.injr_155_19Assessment of liver fibrosis by acoustic radiation force impulse elastography in rheumatic disease patients on long-term methotrexate treatmentArindam Nandy RoyGayatri SenapathyVijay Kumar BonguYarram Ashok KumarSyeda Sana FatimaRegina Lata ThadigiriBackground: Methotrexate treatment has been associated with liver fibrosis in patients with rheumatic disease. Liver biopsy has been the gold standard for staging liver fibrosis. Acoustic Radiation Force Impulse (ARFI) imaging is a new accurate, non-invasive method for staging liver fibrosis. Till date, no study has been conducted to evaluate the diagnostic value of ARFI in patients with rheumatic disease undergoing methotrexate treatment. Study Objective: To assess the degree of liver fibrosis with non-invasive ARFI and to compare the findings with the biochemical parameters in rheumatic disease patients taking methotrexate for long duration. Study Method: We reviewed the medical records of rheumatoid arthritis patients who were administered methotrexate for more than 2 years. A total of 151 patients with rheumatic disease, aged ≥ 18 years were enrolled into the study. In addition, 24 healthy subjects (controls) were recruited to compare the ARFI values with that of patients with rheumatic disease. On the day of the ARFI examination, a series of biochemical parameters were also assessed in the patient group. Pre-defined cut-off ARFI values were used to assess the stage of liver disease. Results: The mean ARFI value in the patient group was 1.14. The mean ARFI values of different rheumatic disease patients were 1.13 (0.0), 1.26 (0.19), 1.16 (0.15), 0.945 (0.21) for Rhupus, rheumatoid arthritis, psoriatic arthritis and Sjogren's syndrome, respectively. Biochemical abnormalities (ALT/AST) were seen in 33 (21.85%) patients. Three patients had ARFI abnormalities (1: cirrhosis and 2: early stage fibrosis). There was no correlation between the ARFI values / biochemical parameters and the cumulative dose of methotrexate. However, the ARFI values correlated with the aspartate aminotransferase (AST), alanine aminotransferase (ALT) and AST to platelet ratio index. Liver fibrosis is rare in rheumatoid arthritis patients treated with a high cumulative dose of methotrexate, and is not accurately detected in patients with liver enzyme abnormalities. Conclusion: Considering the risk and benefit ratio of liver biopsy, ARFI may be a useful non- invasive diagnostic tool for the monitoring hepatic toxicity in patients with rheumatic disease undergoing methotrexate treatment.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=2;spage=111;epage=115;aulast=Royacoustic radiation force impulse imaging elastographyaspartate aminotransferase-to-platelet count ratio indexliver fibrosismethotrexaterheumatic diseases
spellingShingle Arindam Nandy Roy
Gayatri Senapathy
Vijay Kumar Bongu
Yarram Ashok Kumar
Syeda Sana Fatima
Regina Lata Thadigiri
Assessment of liver fibrosis by acoustic radiation force impulse elastography in rheumatic disease patients on long-term methotrexate treatment
Indian Journal of Rheumatology
acoustic radiation force impulse imaging elastography
aspartate aminotransferase-to-platelet count ratio index
liver fibrosis
methotrexate
rheumatic diseases
title Assessment of liver fibrosis by acoustic radiation force impulse elastography in rheumatic disease patients on long-term methotrexate treatment
title_full Assessment of liver fibrosis by acoustic radiation force impulse elastography in rheumatic disease patients on long-term methotrexate treatment
title_fullStr Assessment of liver fibrosis by acoustic radiation force impulse elastography in rheumatic disease patients on long-term methotrexate treatment
title_full_unstemmed Assessment of liver fibrosis by acoustic radiation force impulse elastography in rheumatic disease patients on long-term methotrexate treatment
title_short Assessment of liver fibrosis by acoustic radiation force impulse elastography in rheumatic disease patients on long-term methotrexate treatment
title_sort assessment of liver fibrosis by acoustic radiation force impulse elastography in rheumatic disease patients on long term methotrexate treatment
topic acoustic radiation force impulse imaging elastography
aspartate aminotransferase-to-platelet count ratio index
liver fibrosis
methotrexate
rheumatic diseases
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=2;spage=111;epage=115;aulast=Roy
work_keys_str_mv AT arindamnandyroy assessmentofliverfibrosisbyacousticradiationforceimpulseelastographyinrheumaticdiseasepatientsonlongtermmethotrexatetreatment
AT gayatrisenapathy assessmentofliverfibrosisbyacousticradiationforceimpulseelastographyinrheumaticdiseasepatientsonlongtermmethotrexatetreatment
AT vijaykumarbongu assessmentofliverfibrosisbyacousticradiationforceimpulseelastographyinrheumaticdiseasepatientsonlongtermmethotrexatetreatment
AT yarramashokkumar assessmentofliverfibrosisbyacousticradiationforceimpulseelastographyinrheumaticdiseasepatientsonlongtermmethotrexatetreatment
AT syedasanafatima assessmentofliverfibrosisbyacousticradiationforceimpulseelastographyinrheumaticdiseasepatientsonlongtermmethotrexatetreatment
AT reginalatathadigiri assessmentofliverfibrosisbyacousticradiationforceimpulseelastographyinrheumaticdiseasepatientsonlongtermmethotrexatetreatment